Adiposogenital dystrophy differential diagnosis

	Adiposogenital dystrophy Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Adiposogenital dystrophy from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Head X Ray
CT
MRI
Vision Test
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Adiposogenital dystrophy differential diagnosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Adiposogenital dystrophy differential diagnosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Adiposogenital dystrophy differential diagnosis
CDC on Adiposogenital dystrophy differential diagnosis
Adiposogenital dystrophy differential diagnosis in the news
Blogs on Adiposogenital dystrophy differential diagnosis
Directions to Hospitals Treating Adiposogenital dystrophy
Risk calculators and risk factors for Adiposogenital dystrophy differential diagnosis

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Ogechukwu Hannah Nnabude, MD

Overview

Adiposogenital dystrophy must be differentiated from other diseases that cause polyphagia, obesity, and a delayed puberty such as Prader-Willi syndrome, Bardet-Biedl syndrome, Klinefelter's syndrome and Borjeson syndrome.

Differentiating Adiposogenital Dystrophy from Other Diseases


Disease/Condition	Clinical presentation	Demographics/History	Diagnosis	Treatment

Adiposogenital Dystrophy	Partial destruction of hypothalamic nuclei resulting in hormonal dysfunction with obesity, growth retardation, and hypogonadism. Deep brain stimulation may also cause symptoms similar to adiposogenital syndrome ^[1] ^[2].	Prevalence is unknown, but it is more common in males ^[3] ^[4]	Diagnosis is based on visual field tests, hormonal assays, CT, MRI, autoimmune assays	Diet and exercise Radiation Surgery, thermoablation, radiosurgery Hormone replacement^[5]
Prader-Willi Syndrome	It presents with hyperphagia, hypogonadism, truncal obesity, intellectual disability, growth delay, hypotonia, almond-shaped palpebral fissures, narrow frontal diameter, thin upper vermilion with downturned corners of the mouth behavioral problems such as anxiety and temper outbursts ^[6]	Prader Willi Syndrome has a prevalence of 1 in every 1 in 20000 to 1 in 30000 births^[7]. Females and males can be equally affected, and there is no difference between races and ethnicities^[8]. Most cases of Prader Willi syndrome are sporadic, but familial cases can present when the paternal genes carry a microdeletion in the imprinting center inherited from his mother^[9].	Molecular testing for DNA methylation Fluorescence In Situ Hybridization to investigate 15q11-q13 Chromosomal microarray to determine presence of maternal disomy^[9].	Hormone replacement^[10] Cognitive and behavioral therapy^[11]
Bardet-Biedl Syndrome	Visual impairment Polydactyly, brachydactyly or syndactyly Obesity Renal and genital abnormalities Neurological and mental deficits such as learning difficulties developmental delay, speech deficit, ataxia Diabetes mellitus Congenital heart disease	It is a rare autosomal recessive genetic disorder. ^[12]. Males and females are affected equally^[13]. Increased in the Arab population of Kuwait at a prevalence of approximately 1:13500^[14]	Bardet–Biedl syndrome mutations can be diagnosed by genomic sequencing which would show the coding regions of the genes implicated in causing the disease^[15].	Treatment is symptomatic with focus on managing co=morbidities especially diabetes, hypertension, and obesity ^[16].
Klinefelter Syndrome	Gynecomastia Azoospermia and infertility Dyslipidemia Obesity Increased risk for osteoporosis, autoimmune diseases and neoplasia Impaired social skills Insulin resistance	It is the most common chromosomal disorder in males with about 1:500 to 1:650 affected. ^[17] ^[18].	Klinefelter syndrome can be definitively diagnosed by chromosomal karyotyping ^[17]	It is treated by testosterone replacement therapy^[17].
Börjeson-Forssman-Lehmann syndrome	Visual impairment Intellectual disability Polyneuropathy Epilepsy Cleft palate Obesity Gynecomastia	It is a rare X-linked recessive genetic disorder. Females rarely show symptoms or have mild symptom	Diagnosis is confirmed by the identification of a PHF6 mutation^[19].	Surgery for cleft palate and cryptorchidism Medication can help with epilepsy

References

↑ Tuite PJ, Maxwell RE, Ikramuddin S, Kotz CM, Kotzd CM, Billington CJ; et al. (2005). "Weight and body mass index in Parkinson's disease patients after deep brain stimulation surgery". Parkinsonism Relat Disord. 11 (4): 247–52. doi:10.1016/j.parkreldis.2005.01.006. PMID 15878586.
↑ Romito LM, Scerrati M, Contarino MF, Iacoangeli M, Bentivoglio AR, Albanese A (2003) Bilateral high frequency subthalamic stimulation in Parkinson’s disease: long-term neurological follow-up. J Neurosurg Sci 47:119–128 Medline
↑ Babinski-fröhlich syndrome. Bissonnette B, & Luginbuehl I, & Marciniak B, & Dalens B.J.(Eds.), (2006). Syndromes: Rapid Recognition and Perioperative Implications. McGraw Hill. https://accessanesthesiology.mhmedical.com/content.aspx?bookid=852&sectionid=49517244
↑ Burfeind KG, Yadav V, Marks DL. Hypothalamic Dysfunction and Multiple Sclerosis: Implications for Fatigue and Weight Dysregulation. Curr Neurol Neurosci Rep. 2016 Nov;16(11):98.
↑ Sanchez Jimenez JG, De Jesus O. Hypothalamic Dysfunction. [Updated 2021 Aug 30]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-
↑ Fermin Gutierrez MA, Mendez MD. Prader-Willi Syndrome. [Updated 2021 Aug 11]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-.
↑ Pacoricona Alfaro DL, Lemoine P, Ehlinger V, Molinas C, Diene G, Valette M; et al. (2019). "Causes of death in Prader-Willi syndrome: lessons from 11 years' experience of a national reference center". Orphanet J Rare Dis. 14 (1): 238. doi:10.1186/s13023-019-1214-2. PMC 6829836 Check |pmc= value (help). PMID 31684997.
↑ Bohonowych J, Miller J, McCandless SE, Strong TV (2019). "The Global Prader-Willi Syndrome Registry: Development, Launch, and Early Demographics". Genes (Basel). 10 (9). doi:10.3390/genes10090713. PMC 6770999 Check |pmc= value (help). PMID 31540108.
↑ ^9.0 ^9.1 Butler MG, Manzardo AM, Forster JL (2016). "Prader-Willi Syndrome: Clinical Genetics and Diagnostic Aspects with Treatment Approaches". Curr Pediatr Rev. 12 (2): 136–66. doi:10.2174/1573396312666151123115250. PMC 6742515 Check |pmc= value (help). PMID 26592417.
↑ Cassidy SB, Schwartz S, Miller JL, Driscoll DJ (2012) Prader-Willi syndrome. Genet Med 14 (1):10-26. DOI:10.1038/gim.0b013e31822bead0 PMID: 22237428
↑ Passone CBG, Pasqualucci PL, Franco RR, Ito SS, Mattar LBF, Koiffmann CP; et al. (2018). "PRADER-WILLI SYNDROME: WHAT IS THE GENERAL PEDIATRICIAN SUPPOSED TO DO? - A REVIEW". Rev Paul Pediatr. 36 (3): 345–352. doi:10.1590/1984-0462/;2018;36;3;00003. PMC 6202899. PMID 30365815.
↑ Suspitsin EN, Imyanitov EN (2016). "Bardet-Biedl Syndrome". Mol Syndromol. 7 (2): 62–71. doi:10.1159/000445491. PMC 4906432. PMID 27385962.
↑ Bardet-biedl syndrome. Bissonnette B, & Luginbuehl I, & Marciniak B, & Dalens B.J.(Eds.), (2006). Syndromes: Rapid Recognition and Perioperative Implications. McGraw Hill. https://accessanesthesiology.mhmedical.com/content.aspx?bookid=852&sectionid=49517256
↑ Bardet-biedl syndrome. Bissonnette B, & Luginbuehl I, & Marciniak B, & Dalens B.J.(Eds.), (2006). Syndromes: Rapid Recognition and Perioperative Implications. McGraw Hill. https://accessanesthesiology.mhmedical.com/content.aspx?bookid=852&sectionid=49517256
↑ Bardet-biedl syndrome. Bissonnette B, & Luginbuehl I, & Marciniak B, & Dalens B.J.(Eds.), (2006). Syndromes: Rapid Recognition and Perioperative Implications. McGraw Hill. https://accessanesthesiology.mhmedical.com/content.aspx?bookid=852&sectionid=49517256
↑ Forsythe E, Kenny J, Bacchelli C, Beales PL (2018). "Managing Bardet-Biedl Syndrome-Now and in the Future". Front Pediatr. 6: 23. doi:10.3389/fped.2018.00023. PMC 5816783. PMID 29487844.
↑ ^17.0 ^17.1 ^17.2 Smyth CM, Bremner WJ (1998). "Klinefelter syndrome". Arch Intern Med. 158 (12): 1309–14. doi:10.1001/archinte.158.12.1309. PMID 9645824.
↑ Kanakis GA, Nieschlag E (2018). "Klinefelter syndrome: more than hypogonadism". Metabolism. 86: 135–144. doi:10.1016/j.metabol.2017.09.017. PMID 29382506.
↑ Gécz J, Turner G, Nelson J, Partington M (2006). "The Börjeson-Forssman-Lehman syndrome (BFLS, MIM #301900)". Eur J Hum Genet. 14 (12): 1233–7. doi:10.1038/sj.ejhg.5201639. PMID 16912705.

Template:WH Template:WS

[pmid15878586-1] Tuite PJ, Maxwell RE, Ikramuddin S, Kotz CM, Kotzd CM, Billington CJ; et al. (2005). "Weight and body mass index in Parkinson's disease patients after deep brain stimulation surgery". Parkinsonism Relat Disord. 11 (4): 247–52. doi:10.1016/j.parkreldis.2005.01.006. PMID 15878586.

[2] Romito LM, Scerrati M, Contarino MF, Iacoangeli M, Bentivoglio AR, Albanese A (2003) Bilateral high frequency subthalamic stimulation in Parkinson’s disease: long-term neurological follow-up. J Neurosurg Sci 47:119–128 Medline

[3] Babinski-fröhlich syndrome. Bissonnette B, & Luginbuehl I, & Marciniak B, & Dalens B.J.(Eds.), (2006). Syndromes: Rapid Recognition and Perioperative Implications. McGraw Hill. https://accessanesthesiology.mhmedical.com/content.aspx?bookid=852&sectionid=49517244

[4] Burfeind KG, Yadav V, Marks DL. Hypothalamic Dysfunction and Multiple Sclerosis: Implications for Fatigue and Weight Dysregulation. Curr Neurol Neurosci Rep. 2016 Nov;16(11):98.

[5] Sanchez Jimenez JG, De Jesus O. Hypothalamic Dysfunction. [Updated 2021 Aug 30]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-

[6] Fermin Gutierrez MA, Mendez MD. Prader-Willi Syndrome. [Updated 2021 Aug 11]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-.

[pmid31684997-7] Pacoricona Alfaro DL, Lemoine P, Ehlinger V, Molinas C, Diene G, Valette M; et al. (2019). "Causes of death in Prader-Willi syndrome: lessons from 11 years' experience of a national reference center". Orphanet J Rare Dis. 14 (1): 238. doi:10.1186/s13023-019-1214-2. PMC 6829836 Check |pmc= value (help). PMID 31684997.

[pmid31540108-8] Bohonowych J, Miller J, McCandless SE, Strong TV (2019). "The Global Prader-Willi Syndrome Registry: Development, Launch, and Early Demographics". Genes (Basel). 10 (9). doi:10.3390/genes10090713. PMC 6770999 Check |pmc= value (help). PMID 31540108.

[pmid26592417-9] 9.0 ^9.1 Butler MG, Manzardo AM, Forster JL (2016). "Prader-Willi Syndrome: Clinical Genetics and Diagnostic Aspects with Treatment Approaches". Curr Pediatr Rev. 12 (2): 136–66. doi:10.2174/1573396312666151123115250. PMC 6742515 Check |pmc= value (help). PMID 26592417.

[pmid22237428-10] Cassidy SB, Schwartz S, Miller JL, Driscoll DJ (2012) Prader-Willi syndrome. Genet Med 14 (1):10-26. DOI:10.1038/gim.0b013e31822bead0 PMID: 22237428

[pmid30365815-11] Passone CBG, Pasqualucci PL, Franco RR, Ito SS, Mattar LBF, Koiffmann CP; et al. (2018). "PRADER-WILLI SYNDROME: WHAT IS THE GENERAL PEDIATRICIAN SUPPOSED TO DO? - A REVIEW". Rev Paul Pediatr. 36 (3): 345–352. doi:10.1590/1984-0462/;2018;36;3;00003. PMC 6202899. PMID 30365815.

[pmid27385962-12] Suspitsin EN, Imyanitov EN (2016). "Bardet-Biedl Syndrome". Mol Syndromol. 7 (2): 62–71. doi:10.1159/000445491. PMC 4906432. PMID 27385962.

[13] Bardet-biedl syndrome. Bissonnette B, & Luginbuehl I, & Marciniak B, & Dalens B.J.(Eds.), (2006). Syndromes: Rapid Recognition and Perioperative Implications. McGraw Hill. https://accessanesthesiology.mhmedical.com/content.aspx?bookid=852&sectionid=49517256

[14] Bardet-biedl syndrome. Bissonnette B, & Luginbuehl I, & Marciniak B, & Dalens B.J.(Eds.), (2006). Syndromes: Rapid Recognition and Perioperative Implications. McGraw Hill. https://accessanesthesiology.mhmedical.com/content.aspx?bookid=852&sectionid=49517256

[15] Bardet-biedl syndrome. Bissonnette B, & Luginbuehl I, & Marciniak B, & Dalens B.J.(Eds.), (2006). Syndromes: Rapid Recognition and Perioperative Implications. McGraw Hill. https://accessanesthesiology.mhmedical.com/content.aspx?bookid=852&sectionid=49517256

[pmid29487844-16] Forsythe E, Kenny J, Bacchelli C, Beales PL (2018). "Managing Bardet-Biedl Syndrome-Now and in the Future". Front Pediatr. 6: 23. doi:10.3389/fped.2018.00023. PMC 5816783. PMID 29487844.

[pmid9645824-17] 17.0 ^17.1 ^17.2 Smyth CM, Bremner WJ (1998). "Klinefelter syndrome". Arch Intern Med. 158 (12): 1309–14. doi:10.1001/archinte.158.12.1309. PMID 9645824.

[pmid29382506-18] Kanakis GA, Nieschlag E (2018). "Klinefelter syndrome: more than hypogonadism". Metabolism. 86: 135–144. doi:10.1016/j.metabol.2017.09.017. PMID 29382506.

[pmid16912705-19] Gécz J, Turner G, Nelson J, Partington M (2006). "The Börjeson-Forssman-Lehman syndrome (BFLS, MIM #301900)". Eur J Hum Genet. 14 (12): 1233–7. doi:10.1038/sj.ejhg.5201639. PMID 16912705.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

[11]

[12]

[13]

[14]

[15]

[16]

[17]

[18]

[19]

Adiposogenital dystrophy differential diagnosis

Overview

Differentiating Adiposogenital Dystrophy from Other Diseases

References

Navigation menu